Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases

INTRODUCTION: In the western hemisphere, age-related macular degeneration (AMD) is the leading cause of visual loss in the elderly. Currently approved therapies for AMD include argon laser, photodynamic therapy, and antivascular endothelial growth factor (VEGF) therapy. The index review discusses af...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sophie, Raafay, Akhtar, Abeer, Sepah, Yasir J., Ibrahim, Mohamed, Bittencourt, Millena, Do, Diana V., Nguyen, Quan Dong
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare Communications 2012
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3873045/
https://ncbi.nlm.nih.gov/pubmed/24392297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13554-012-0003-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars